Ambient PM<sub>2.5</sub> exposure and hospital cost and length of hospital stay for respiratory diseases in 11 cities in Shanxi Province, China.

Cao, Dawei; Li, Dongyan; Wu, Yinglin; Qian, Zhengmin Min; Liu, Yi; Liu, Qiyong; Sun, Jimin; Guo, Yuming et al. · Thorax · 2021

cross_sectional · Level IV

Where this comes from

Abstract

Few studies have examined the effects of ambient particulate matter with an aerodynamic diameter less than or equal to 2.5 μm (PM<sub>2.5</sub>) on hospital cost and length of hospital stay for respiratory diseases in China. We estimated ambient air pollution exposure for respiratory cases through inverse distance-weighted averages of air monitoring stations based on their residential address and averaged at the city level. We used generalised additive models to quantify city-specific associations in 11 cities in Shanxi and a meta-analysis to estimate the overall effects. We further estimated respiratory burden attributable to PM<sub>2.5</sub> using the standards of WHO (25 µg/m<sup>3</sup>) and China (75 µg/m<sup>3</sup>) as reference. Each 10 µg/m<sup>3</sup> increase in lag<sub>03</sub> PM<sub>2.5</sub> corresponded to 0.53% (95% CI: 0.33% to 0.73%) increase in respiratory hospitalisation, an increment of 3.75 thousand RMB (95% CI: 1.84 to 5.670) in hospital cost and 4.13 days (95% CI: 2.51 to 5.75) in length of hospital stay. About 9.7 thousand respiratory hospitalisations, 132 million RMB in hospital cost and 145 thousand days of hospital stay could be attributable to PM<sub>2.5</sub> exposures using WHO's guideline as reference. We estimated that 193 RMB (95% CI: 95 to 292) in hospital cost and 0.21 days (95% CI: 0.13 to 0.30) in hospital stay could be potentially avoidable for an average respiratory case. Significant respiratory burden could be attributable to PM<sub>2.5</sub> exposures in Shanxi Province, China. The results need to be factored into impact assessment of air pollution policies to provide a more complete indication of the burden addressed by the policies.